Related Experiment Videos
Sideroblasts and haemosiderin in thyrotoxicosis
Scandinavian Journal of Haematology
|September 1, 1980
Summary
Thyrotoxicosis increases iron supply to red blood cell precursors (erythroblasts), leading to higher iron levels in bone marrow sideroblasts and haemosiderin stores. This indicates an imbalance between iron availability and hemoglobin synthesis during hyperthyroidism.
Area of Science:
- Hematology
- Endocrinology
- Iron Metabolism
Background:
- Thyrotoxicosis, a hypermetabolic state, can affect various bodily functions, including iron metabolism.
- Understanding iron dynamics in red blood cell production is crucial for diagnosing and managing related disorders.
Purpose of the Study:
- To investigate the impact of thyrotoxicosis on bone marrow sideroblasts and haemosiderin levels.
- To compare iron storage and utilization in erythroblasts during hyperthyroid and euthyroid states.
Main Methods:
- Bone marrow samples were analyzed from 19 patients with thyrotoxicosis.
- Samples were examined both before thyroid treatment (hyperthyroid state) and after achieving a euthyroid state.
Main Results:
- A significantly higher proportion of sideroblasts and greater amounts of haemosiderin were observed in the hyperthyroid phase compared to the euthyroid phase.
- Pathological sideroblasts, characterized by coarse perinuclear iron granules, were present before therapy but absent in the euthyroid state.
Conclusions:
- Thyrotoxicosis enhances the iron supply to erythroblasts beyond the requirements for hemoglobin synthesis.
- Altered iron kinetics in bone marrow are a characteristic feature of thyrotoxicosis.